Moreover, investigation of differentially expressed transcripts in livers of people with non-alcoholic fatty liver disease (NAFLD) found that SCLY was downregulated in non-alcoholic steatohepatitis (NASH) compared with healthy controls [17]. The gene discussed is SCLY; the disease is metabolic dysfunction-associated steatohepatitis.